CASI icon

CASI Pharmaceuticals

64 hedge funds and large institutions have $50.2M invested in CASI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 7 closing their positions.

Holders
64
Holders Change
+6
Holders Change %
+10.34%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
22
Reduced
12
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$28K 5,974 +5,974 New
AIP
52
Ameritas Investment Partners
Nebraska
$20K 4,345
LTFS
53
Ladenburg Thalmann Financial Services
Florida
$9K 2,046
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$7.62K 1,632 -2 -0.1%
Bank of Montreal
55
Bank of Montreal
Ontario, Canada
$2K 344 -10 -3%
WSTAM
56
Wilbanks Smith & Thomas Asset Management
Virginia
$1K 161 +161 New
SPIA
57
Steward Partners Investment Advisory
New York
$1K 200 +200 New
MC
58
Moors & Cabot
Massachusetts
-22,935 Closed
TSS
59
Two Sigma Securities
New York
-22,803 Closed
Millennium Management
60
Millennium Management
New York
-17,866 Closed
CS
61
Credit Suisse
Switzerland
-14,805 Closed
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
-10,191 Closed
PIA
63
Piedmont Investment Advisors
North Carolina
-866 Closed
RFM
64
Royal Fund Management
Florida
$0 4 -5 -56%
IA
65
IFP Advisors
Florida
-2 Closed
AG
66
Advisor Group
Arizona
$0 90
CFGS
67
Concourse Financial Group Securities
Alabama
FWM
68
Focused Wealth Management
New York
$0 45
CPIG
69
Chicago Partners Investment Group
Illinois
$0 27
HNB
70
Huntington National Bank
Ohio
$0 18 +18 New
RWA
71
River Wealth Advisors
Pennsylvania
$0 50 +50 New
Fidelity Investments
72
Fidelity Investments
Massachusetts
$0 78 +78 New